| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $257.3M | +1.4% |
| Cost of Revenue | $146.1M | -1.2% |
| Gross Profit | $111.2M | +5.1% |
| R&D Expense | $19.8M | +182.9% |
| SG&A Expense | $64.1M | +17.5% |
| Operating Income | -$20.3M | -1944.1% |
| Interest Expense | $4.2M | -0.2% |
| Pre-tax Income | -$21.8M | -534.5% |
| Income Tax | -$3.4M | +4.6% |
| Net Income | -$19.9M | -1632.5% |
| EPS (Basic) | -$1.92 | -1645.5% |
| EPS (Diluted) | -$1.92 | -1645.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $156.6M | -29.9% |
| Accounts Receivable | $29.5M | +5.4% |
| Inventory | $60.0M | +21.7% |
| Current Assets | $265.0M | -17.1% |
| Total Assets | $585.8M | -3.0% |
| Current Liabilities | $39.6M | -9.9% |
| Total Liabilities | $163.6M | -2.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.8M | -449.2% |
| Investing Cash Flow | -$35.8M | -2.2% |
| Financing Cash Flow | -$7.1M | -104.2% |
| Stockholders' Equity |
| $422.2M |
| -3.1% |